U.S. markets open in 7 hours 19 minutes

TELA Bio, Inc. (TELA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.90-0.40 (-3.01%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close13.30
Open13.42
Bid0.00 x 800
Ask0.00 x 800
Day's Range12.81 - 13.42
52 Week Range10.77 - 23.55
Volume21,418
Avg. Volume29,532
Market Cap186.282M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.23
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
      Zacks

      TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

      TELA Bio, Inc. (TELA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    • TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript
      Motley Fool

      TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript

      Ladies and gentlemen, thank you for standing by, and welcome to the TELA Bio fourth quarter earnings conference call. Earlier today, TELA Bio released financial results for the fourth quarter and year ended December 31, 2020. Joining me on today's call are Tony Koblish, president and CEO; and Nora Brennan, CFO.

    • TELA Bio to Announce First Quarter 2021 Financial Results
      GlobeNewswire

      TELA Bio to Announce First Quarter 2021 Financial Results

      MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the company will report first quarter ended March 31, 2021, financial results on Thursday, May 13, 2021. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast DetailsThe conference call can be accessed by dialing 855-548-1219 for participants in the U.S. or Canada and 409-217-8881 for international callers, using conference ID 7381947. A live and archived webcast of the event can be accessed via the Events & Presentations page of the investor section of TELA's website. About TELA Bio, Inc.TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to providing advanced, economically effective biologic material repair solutions to patients to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio’s OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. For more information, visit www.telabio.com. Investor ContactGreg Chodaczek347-620-7010 ir@telabio.com